Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Assets in USD from Q4 2020 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Assets history and growth rate from Q4 2020 to Q4 2023.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Assets for the quarter ending December 31, 2023 was $3.42M, a 62.6% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$3.42M	+$1.32M	+62.6%	Dec 31, 2023	20-F	2024-07-05
Q3 2023	$1.8M			Sep 30, 2023	6-K	2023-11-13
Q4 2022	$2.1M	-$1.16M	-35.5%	Dec 31, 2022	20-F	2024-07-05
Q4 2021	$3.26M	+$437K	+15.5%	Dec 31, 2021	20-F	2023-05-15
Q4 2020	$2.83M			Dec 31, 2020	20-F	2023-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.